BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31443731)

  • 1. Regional lymphadenectomy vs. extended lymphadenectomy for hilar cholangiocarcinoma (Relay-HC trial): study protocol for a prospective, multicenter, randomized controlled trial.
    He M; Xu X; Feng H; Chen W; Liu H; Zhang Y; Wang J; Geng Z; Qiu Y; Duan W; Li X; Zhi X; Zhu W; Li F; Li J; Li S; He Y; Quan Z; Wang J
    Trials; 2019 Aug; 20(1):528. PubMed ID: 31443731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended lymphadenectomy in hilar cholangiocarcinoma: What it will bring?
    Li J; Zhou MH; Ma WJ; Li FY; Deng YL
    World J Gastroenterol; 2020 Jun; 26(24):3318-3325. PubMed ID: 32655260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Radical Extent of lymphadenectomy - D2 dissection versus complete mesocolic excision of LAparoscopic Right Colectomy for right-sided colon cancer (RELARC) trial: study protocol for a randomized controlled trial.
    Lu JY; Xu L; Xue HD; Zhou WX; Xu T; Qiu HZ; Wu B; Lin GL; Xiao Y
    Trials; 2016 Dec; 17(1):582. PubMed ID: 27931247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma.
    Zhang XF; Bagante F; Chen Q; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
    Surgery; 2018 May; 163(5):1114-1120. PubMed ID: 29398035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
    World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pure laparoscopic radical resection for type IIIa hilar cholangiocarcinoma.
    Zhang CW; Liu J; Hong DF; Wang ZF; Hu ZM; Huang DS; Shang MJ; Yao WF
    Surg Endosc; 2018 Mar; 32(3):1581-1582. PubMed ID: 28779241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
    Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma.
    Mao K; Liu J; Sun J; Zhang J; Chen J; Pawlik TM; Jacobs LK; Xiao Z; Wang J
    J Gastroenterol Hepatol; 2016 Feb; 31(2):417-26. PubMed ID: 26250532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors.
    Kimura N; Young AL; Toyoki Y; Wyatt JI; Toogood GJ; Hidalgo E; Prasad KR; Kudo D; Ishido K; Hakamada K; Lodge JPA
    Surgery; 2017 Sep; 162(3):500-514. PubMed ID: 28551378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liver transplantation for hilar cholangiocarcinoma].
    Rauchfuss F; Utess F; Schüle S; Dittmar Y; Scheuerlein H; Settmacher U
    Chirurg; 2012 Mar; 83(3):229-37. PubMed ID: 22273852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left hepatectomy combined with hepatic artery resection for hilar cholangiocarcinoma: A retrospective cohort study.
    Peng C; Li C; Wen T; Yan L; Li B
    Int J Surg; 2016 Aug; 32():167-73. PubMed ID: 27344254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
    Yan Y; Lu N; Tian W; Liu T
    Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended Lymphadenectomy Versus Regional Lymphadenectomy in Resectable Hilar Cholangiocarcinoma.
    Ma WJ; Wu ZR; Hu HJ; Wang JK; Yin CH; Shi YJ; Li FY; Cheng NS
    J Gastrointest Surg; 2020 Jul; 24(7):1619-1629. PubMed ID: 31147975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
    Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
    World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node dissection in resectable perihilar cholangiocarcinoma: a systematic review.
    Kambakamba P; Linecker M; Slankamenac K; DeOliveira ML
    Am J Surg; 2015 Oct; 210(4):694-701. PubMed ID: 26212390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical therapy of hilar cholangiocarcinoma].
    Lang H; Kaiser GM; Zöpf T; Sotiropoulos GC; Frilling A; Malagó M; Broelsch CE
    Chirurg; 2006 Apr; 77(4):325-34. PubMed ID: 16568258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?
    Hakeem AR; Marangoni G; Chapman SJ; Young RS; Nair A; Hidalgo EL; Toogood GJ; Wyatt JI; Lodge PA; Prasad KR
    Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1047-54. PubMed ID: 25051217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined vascular resection and analysis of prognostic factors for hilar cholangiocarcinoma.
    Wang ST; Shen SL; Peng BG; Hua YP; Chen B; Kuang M; Li SQ; He Q; Liang LJ
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):626-32. PubMed ID: 26663011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.
    Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS
    World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
    Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
    Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.